[In vitro activity of ceftazidime- avibactam and ceftolozane- tazobactam against clinical isolates of enterobacteriaceae and <i>pseudomonas æruginosa</i>: results from a trauma center and burn unit in tunisia].

Antibiotic resistance is an escalating public health challenge, particularly among Enterobacteriaceae and <i>Pseudomonas aeruginosa</i>. In this study conducted at a burn center in Tunisia, we collected 307 non-redundant strains of Enterobacteriaceae from predominantly hospitalized patients, with a majority in the burn intensive care unit (59%), the primary identified species being <i>Klebsiella pneumoniae</i> (34.8%). We evaluated the efficacy of two antibiotics, ceftazidime-avibactam (CZA) and ceftolozane-tazobactam (CT). The results revealed that the overall resistance to CZA was 11.7%, while to CT it was 25.7%. CZA proved to be the second most sensitive molecule among all tested antibiotics, following fosfomycin. Among strains resistant to third-generation cephalosporins, 73.3% were sensitive to CZA, and 41.5% to CT. Out of seventy-nine CT-resistant strains, eight were ESBL producers, twenty-two were high-level cephalosporinases, thirty-three carried <i>blaNDM</i>, twelve carried <i>blaOXA48</i>, and four carried both <i>blaNDM</i> and <i>blaOXA-48</i>. Indeed, <i>blaNDM</i> were the most prevalent carbapenemases. For <i>Pseudomonas aeruginosa</i> strains (n=161), resistance to CZA was 42.2%, and to CT it was 47.8%. These antibiotics ranked as the second and third most active beta-lactams after aztreonam. Among the 71 strains of CZA and carbapenem-resistant P. aeruginosa, 54.1% produced VIM2. Resistance to enterobacteriaceae against CZA and CT is relatively high in our study. However, CZA remains a salvage therapy for infections caused by carbapenem-resistant organisms, and its use should be considered only after documentation and in the absence of other alternatives among β-lactams. For <i>P. aeruginosa</i>, CZA currently represents the most active β-lactam against CAZ-R strains and the second most active molecule overall, including those producing carbapenemases.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-03-01
Citations
1
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[In vitro activity of ceftazidime- avibactam and ceftolozane- tazobactam against clinical isolates of enterobacteriaceae and pseudomonas æruginosa: results from a trauma center and burn unit in tunisia].

S. Dhraief, A A Messadi, M. Lamloumi, B Maamar et al.
1 citations
PubMed
Antibiotic Resistance in Bacteria
article

[In vitro activity of ceftazidime- avibactam and ceftolozane- tazobactam against clinical isolates of enterobacteriaceae and pseudomonas æruginosa: results from a trauma center and burn unit in tunisia].

S. Dhraief, A A Messadi, M. Lamloumi, B Maamar, Z. Megdiche, Lamia Thabet
article en
1 citations

Abstract

Antibiotic resistance is an escalating public health challenge, particularly among Enterobacteriaceae and <i>Pseudomonas aeruginosa</i>. In this study conducted at a burn center in Tunisia, we collected 307 non-redundant strains of Enterobacteriaceae from predominantly hospitalized patients, with a majority in the burn intensive care unit (59%), the primary identified species being <i>Klebsiella pneumoniae</i> (34.8%). We evaluated the efficacy of two antibiotics, ceftazidime-avibactam (CZA) and ceftolozane-tazobactam (CT). The results revealed that the overall resistance to CZA was 11.7%, while to CT it was 25.7%. CZA proved to be the second most sensitive molecule among all tested antibiotics, following fosfomycin. Among strains resistant to third-generation cephalosporins, 73.3% were sensitive to CZA, and 41.5% to CT. Out of seventy-nine CT-resistant strains, eight were ESBL producers, twenty-two were high-level cephalosporinases, thirty-three carried <i>blaNDM</i>, twelve carried <i>blaOXA48</i>, and four carried both <i>blaNDM</i> and <i>blaOXA-48</i>. Indeed, <i>blaNDM</i> were the most prevalent carbapenemases. For <i>Pseudomonas aeruginosa</i> strains (n=161), resistance to CZA was 42.2%, and to CT it was 47.8%. These antibiotics ranked as the second and third most active beta-lactams after aztreonam. Among the 71 strains of CZA and carbapenem-resistant P. aeruginosa, 54.1% produced VIM2. Resistance to enterobacteriaceae against CZA and CT is relatively high in our study. However, CZA remains a salvage therapy for infections caused by carbapenem-resistant organisms, and its use should be considered only after documentation and in the absence of other alternatives among β-lactams. For <i>P. aeruginosa</i>, CZA currently represents the most active β-lactam against CAZ-R strains and the second most active molecule overall, including those producing carbapenemases.

PubMedVol. 38(1)
Tunis University (TN), Tunis El Manar University (TN), Imation (United States) (US)
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.